The first RoundUp trial in St. Louis that was scheduled to begin on Wednesday was postponed indefinitely as Monsanto, the manufacturer of the weedkiller, and Bayer, the company that owns Monsanto, are looking to agree on a settlement.
The reason why a settlement is close is because there are now over 50,000 cases throughout the world in which people have obtained cancer from using the herbicide on their property. Also, executives and employees from Monsanto were designated to testify in the St. Louis trial, which the company was looking to prevent.
The settlement is estimated to be around $10 billion. On average, each person would receive $200,000. Another part of the settlement is that lawyers can no longer seek after future clients. That means that when someone else obtains cancer from using RoundUp, then that person will have to seek out his or her own litigation.